Florian Lordick, MD, PhD

Leipzig University Medical Center
Leipzig, Germany

Dr. Lordick is a Full Professor of Medicine at the University of Leipzig, Germany. He was appointed as director of the University Cancer Center Leipzig in 2012. Since 2020, he also chairs the Department of Medicine II (oncology, gastroenterology, hepatology, pulmonology, and infectious diseases) at the Leipzig University Medical Center. Additionally, he was appointed as study dean of the medical faculty.
Since 2020 he is director of education of the European Society for Medical Oncology (ESMO). He also is the past-president of the International Gastric Cancer Association (IGCA) and former chairman of the EORTC GI Tract Cancer Working Group.
Dr. Lordick’s scientific focus is on clinical and translational research in gastrointestinal tract cancers. His research is funded by the German Cancer Aid, the German Ministry of Education and Research and by the European Commission. Dr. Lordick has authored and co-authored more than 400 peer-reviewed articles and book chapters. Since 2021 he is deputy-editor-in-chief of the Journal of Cancer Research and Clinical Oncology (Springer). He volunteers as associated editor of Gastric Cancer, the official scientific journal of IGCA and ESMO Open as well as an editorial board member of Annals of Oncology, official scientific journal of ESMO.

Presentation(s):

• ESMO Vesalius Talk: How to find Local and International Mentors to Build Your Career in GI Oncology

  Wednesday, June 29, 2022
  16:15 – 17:00

• Roundtable Discussion

  Wednesday, June 29, 2022
  19:50 – 20:05

• Session V: Presentation of Selected Non-Colorectal Cancer Abstracts

  Thursday, June 30, 2022
  08:00 – 09:25

• New Targets and Agents in Upper GI Cancer

  Thursday, June 30, 2022
  12:11 – 12:31

• mGC Patient Case

  Thursday, June 30, 2022
  13:50 – 14:10

• Conclusion and Q&A

  Thursday, June 30, 2022
  14:20 – 14:35

• Expert Perspectives on Checkpoint Inhibitors in Gastric Cancer 

  Saturday, July 2, 2022
  13:30 – 15:00

• Welcome and Program Overview

  Saturday, July 2, 2022
  13:30 – 13:35

• Panel Discussion 1: Current Unmet Needs in the Diagnosis and Management of Metastatic G/GEJ Adenocarcinoma

  Saturday, July 2, 2022
  13:50 – 14:05

• 1L Treatment of G/GEJ Adenocarcinoma

  Saturday, July 2, 2022
  14:05 – 14:20

• Panel Discussion 2: Evolution of Treatments and Role of Checkpoint Inhibitors in Locally Advanced, Unresectable or Metastatic G/GEJ Adenocarcinoma

  Saturday, July 2, 2022
  14:20 – 14:35

• Q&A Session

  Saturday, July 2, 2022
  14:35 – 15:00